Current indications for intravenous nutritional support in oncology patients
- PMID: 7552793
Current indications for intravenous nutritional support in oncology patients
Abstract
No clear role has yet been defined for the role of total parenteral nutrition in the management of the cancer patient, and this subject remains an area of controversy. Peri-operative nutritional support, if given for at least 10 days, may reduce morbidity and mortality in some patients, although this subgroup has not been fully characterized. There is no evidence that parenteral nutritional support benefits patients undergoing chemotherapy or radiotherapy in terms of an increased tumor response rate or prolongation of survival.
Similar articles
-
Peri-operative nutritional support: controversies and debates.Int J Surg Investig. 2000;2(2):107-15. Int J Surg Investig. 2000. PMID: 12678508 Review.
-
Do data support nutrition support? Part I: intravenous nutrition.J Am Diet Assoc. 2007 Jun;107(6):988-96; quiz 998. doi: 10.1016/j.jada.2007.03.015. J Am Diet Assoc. 2007. PMID: 17524720 Review.
-
[Perioperatory artificial nutrition].An Med Interna. 2008 Jun;25(6):297-300. An Med Interna. 2008. PMID: 19295980 Review. Spanish.
-
ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology.Clin Nutr. 2009 Aug;28(4):445-54. doi: 10.1016/j.clnu.2009.04.011. Epub 2009 May 23. Clin Nutr. 2009. PMID: 19477052
-
Short-term nutritional implications of total gastrectomy for malignancy, and the impact of parenteral nutritional support.Clin Nutr. 2007 Dec;26(6):718-27. doi: 10.1016/j.clnu.2007.08.013. Epub 2007 Oct 18. Clin Nutr. 2007. PMID: 17949863